The FDA has accepted for review the New Drug Application for SYD-101 (atropine sulfate) to slow the progression of myopia in children.

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients ... transplant them into the damaged eye. Related: Gene-therapy drops restore teen's vision after genetic ...

Cyclosporine 0.09% significantly improves CFS scores and tear production in patients with uncontrolled dry eye disease, including those with MGD. Scleral lenses offer a non-surgical intervention ...

Geographic disparities and nondiagnostic results challenge AI adoption, necessitating strategies for equitable access and improved image quality in diabetic eye disease management ... sclerosis and ...

After an intense back and forth, the bout had to be halted in the final seconds of the third round when 'Triple C' was struck in the eye. Cejudo was given a five-minute recovery time. However ...

Failure to administer a timely and suitable therapy may lead to corneal opacity, ulceration, significant vision impairment, or potential blindness. Current clinical interventions for bacterial ...